维普中文期刊产品整合服务
16篇 您的检索式:作者名="Gunluoglu"
    题名 作者 年代 出处 被引量
1Tumor angiogenesis in predicting the survival of patients with stage I lung cancer显示文摘Medetoglu B Gunluoglu MZ Demir A 0,,05:1
2Intrapulmonary- located Castleman' s disease, which was surgically reseeted without pulmonary resection 显示文摘Gunluoglu G Olcmen A Sokueu SN 2011Ann Thorae Cardiovasc Surg2011,17,:1
3Surgical treat-ment and prognosis of primitive neuroectodermal tumorsof the thorax显示文摘Demir A Gunluoglu MZ Dagoglu N 2009J Thorac Oncol2009,4,1:1
4Tumor angiogenesis in predicting the survival of patients with stage I lung cancer显示文摘Medetoglu B Gunluoglu MZ Demir A 2010J Thorac Cardiovasc Surg2010,140,5:1
5Value of real-time endo- bronchial ultrasound-guided transbronchial needle aspiration显示文摘Cetinkaya E Gunluoglu G Ozgul A 2011Ann Thorac Med2011,6,2:1
6Tumor angiogenesis in predicting the survival of patients with stage I lung cancer显示文摘Baris Medetoglu Mehmet Zeki Gunluoglu Adalet Demir Huseyin Melek Nur Buyukpinarbasili Neslihan Fener Seyyit Ibrahim Dincer 2010The Journal of Thoracic and Cardiovascular Surgery2010,,5:1
7Role and outcome of surgery for pulmonary tuberculosis显示文摘Olcmen A Gunluoglu MZ Demir A 2006Asian Cardiovasc Thorac Ann2006,14,5:1
8Survival and prognostic factors in surgically resected synchronous multiple primary lung cancers显示文摘Kocaturk CI Gunluoglu MZ Cansever L 2011{H}European Journal of Cardio-thoracic Surgery2011,,02:1
9The prognostic signal cance of skip mediastinal lymphatic metastasis in resected non-small cell lung cancer显示文摘Gunluoglu Z Solak O Metin M 2002EurJ Cardiothorae Surg2002,21,3:1
10Role of positron emission tomography in mediastinal lymphatic staging of non - small celllung cancer显示文摘Melek H Gunluoglu MZ Demir A 2008Eur J Cardiothorac Surg2008,33,:1
11Tumor angio- genesis in predicting the survival of patients with stage I lung cancer 显示文摘Medetoglu B Gunluoglu MZ Dernir A 2010J Thorac Cardiovasc Surg2010,140,5:1
12The prognostic significance of skip mediastinal lymphatic metastasis in resected nonsmall cell lung cancer显示文摘Gunluoglu Z Solak O Metin M 2002Eur J Cardiothorac Surg2002,21,3:1
13Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer 显示文摘Melek H Gunluoglu MZ Demir A 2007Eur J Cardiothorac Surg2007,18,:1
14Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer 显示文摘Melek H Gunluoglu MZ Demir A 2008Eur J Cardiothorac Surg2008,33,:1
15Role and outcome of surgery for pulmonary tuberculosis显示文摘Olcmen A Gunluoglu MZ Demir A 0,,05:1
16Post-discharge mortality in the first wave of COVID-19 in Turkey显示文摘Objective:To determine post-discharge mortality and associated factors of the first-wave multicenter Turkish Thoracic Society(TTD)-TURCOVID study.Methods:In this retrospective cohort study,we analyzed the data of 18 of 26 centers included in the first TTD-TURCOVID study,and 1112 cases diagnosed with COVID-19 between 11 March and 31 July 2020 participated in the study.All causes of death after COVID-19 discharge were recorded.Results:The mean age of the patients was(51.07±16.93)years,with 57.6%male patients.In the cohort group,89.1%of COVID-19 treatment locations were hospital wards,3.6%were intensive care units(ICUs),and 7.2%were community outpatients.In the longterm follow-up,the in-hospital mortality rate was 3.6%(95%CI 2.6-4.8),the post-discharge mortality rate was 2.8%(95%CI 1.9-3.9),and the total mortality was 6.3%(95%CI 5.0-7.8).After discharge,63.3%of mortality overall occurred during the first six months.Mortality rates in post-discharge follow-ups were 12.7%(95%CI 8.0-30.6)in cancer patients,10.8%(95%CI 6.3-22.9)in chronic obstructive pulmonary disease patients,11.1%(95%CI 4.4-22.7)in heart failure patients,7.8(95%CI 3.8-14.3)in atherosclerotic heart disease patients,and 2.3%(95%CI 0.8-5.6)in diabetes mellitus patients.In smokers/ex-smokers,the all-mortality rates were higher than in non-smokers.Conclusions:This multicenter study showed that patients over 65 years of age,males,former/active smoker,ICU stay,lung,heart disease,and malignancy should be followed up for at least the first six months after discharge due to COVID-19.Fusun Fakili Pelin Duru Cetinkaya Oya Baydar Serap Argun Baris Nurdan Kokturk Seval Kul Oguz Karcioglu Pinar Aysert Yildiz Ilim Irmak Yonca Sekibag Emel Azak Sait Mulamahmutoglu Caglar Cuhadaroglu Bugra Kerget Burcu Baran Ketencioglu Hasan Selcuk Ozger Gulcihan Ozkan Zeynep Ture Merve Ercelik Tansu Ulukavak Ciftci Ozlem Alici Esra Nurlu Temel Ozlem Ataoglu Neslihan Kose Muge Meltem Tor Gulsah Gunluoglu Sedat Altin Onder Ozturk Pinar Yildiz Gulhan Ilknur Basyigit Hasim Boyaci I Kivilcim Oguzulgen Sermin Borekci Bilun Gemicioglu Ismail Hanta Hacer Kuzu Okur Gulseren Sagcan Metin Akgun Ali Fuat Kalyoncu Oya Itil Hasan Bayram 2022Asian Pacific Journal of Tropical Medicine2022,15,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费